These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 22674103

  • 1. Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.
    Alam MA, Sami S, Babu S.
    BMJ Case Rep; 2011 Nov 08; 2011():. PubMed ID: 22674103
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.
    Wang XY, Chen Y, Du Q.
    Eur Rev Med Pharmacol Sci; 2013 Apr 08; 17(8):1114-6. PubMed ID: 23661527
    [Abstract] [Full Text] [Related]

  • 3. [Angiogenesis inhibitors for treatment of angiodysplasia-related gastrointestinal bleeding].
    Bauditz J.
    Dtsch Med Wochenschr; 2009 Sep 08; 134(38):1893-6. PubMed ID: 19746332
    [No Abstract] [Full Text] [Related]

  • 4. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?
    Bowcock SJ, Patrick HE.
    Br J Haematol; 2009 Jul 08; 146(2):220-2. PubMed ID: 19438503
    [No Abstract] [Full Text] [Related]

  • 5. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias.
    Dabak V, Kuriakose P, Kamboj G, Shurafa M.
    Dig Dis Sci; 2008 Jun 08; 53(6):1632-5. PubMed ID: 17990111
    [Abstract] [Full Text] [Related]

  • 6. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.
    Bauditz J, Lochs H.
    World J Gastroenterol; 2007 Dec 07; 13(45):5979-84. PubMed ID: 18023086
    [Abstract] [Full Text] [Related]

  • 7. Hemorrhagic angiodysplasia of the digestive tract: pathogenesis, diagnosis, and management.
    Becq A, Rahmi G, Perrod G, Cellier C.
    Gastrointest Endosc; 2017 Nov 07; 86(5):792-806. PubMed ID: 28554655
    [No Abstract] [Full Text] [Related]

  • 8. [Thalidomide therapy for gastrointestinal angiodysplasia].
    Bélard E, Foss CH, Christensen LA, Schmidt P, Nøjgaard C.
    Ugeskr Laeger; 2009 Nov 16; 171(47):3454-5. PubMed ID: 19925735
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment with thalidomide for a patient with recurrent gastrointestinal bleeding due to angiodysplasia diagnosed by capsule endoscopy.
    Tan HH, Ge ZZ, Chen HM, Gao YJ.
    J Dig Dis; 2013 Mar 16; 14(3):153-5. PubMed ID: 23134426
    [No Abstract] [Full Text] [Related]

  • 10. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L, Kundra A, Jervis P.
    J Laryngol Otol; 2018 Oct 16; 132(10):866-871. PubMed ID: 30191780
    [Abstract] [Full Text] [Related]

  • 11. Thalidomide in angiodysplasia-related bleeding.
    Boey JP, Hahn U, Sagheer S, McRae SJ.
    Intern Med J; 2015 Sep 16; 45(9):972-6. PubMed ID: 26332623
    [Abstract] [Full Text] [Related]

  • 12. Gastric angiodysplasia in a hereditary hemorrhagic telangiectasia type 2 patient.
    Ha M, Kim YJ, Kwon KA, Hahm KB, Kim MJ, Kim DK, Lee YJ, Oh SP.
    World J Gastroenterol; 2012 Apr 21; 18(15):1840-4. PubMed ID: 22553411
    [Abstract] [Full Text] [Related]

  • 13. [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias].
    de Koning DB, Drenth JP, Friederich P, Nagengast FM.
    Ned Tijdschr Geneeskd; 2006 Sep 09; 150(36):1994-7. PubMed ID: 17002190
    [Abstract] [Full Text] [Related]

  • 14. Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations.
    Bauditz J.
    World J Gastroenterol; 2016 Mar 21; 22(11):3158-64. PubMed ID: 27003992
    [Abstract] [Full Text] [Related]

  • 15. Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation?
    Muller YD, Oppliger R, Breguet R, Meyer P, Rubbia-Brandt L, Petignat PA, Harr T, Dayer E, Seebach JD.
    Liver Int; 2016 Dec 21; 36(12):1735-1740. PubMed ID: 27864873
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
    Invernizzi R, Quaglia F, Klersy C, Pagella F, Ornati F, Chu F, Matti E, Spinozzi G, Plumitallo S, Grignani P, Olivieri C, Bastia R, Bellistri F, Danesino C, Benazzo M, Balduini CL.
    Lancet Haematol; 2015 Nov 21; 2(11):e465-73. PubMed ID: 26686256
    [Abstract] [Full Text] [Related]

  • 17. [Thalidomide for recurrent gastrointestinal bleeding caused by angiodysplasia: report of one case].
    Vega J, Goecke H, Rodríguez Mde L, Vergara MT.
    Rev Med Chil; 2011 Jul 21; 139(7):909-13. PubMed ID: 22051829
    [Abstract] [Full Text] [Related]

  • 18. Tranexamic acid may be a useful pharmacotherapy for endoscopically resistant small bowel angiodysplasia.
    Fujimori S.
    World J Gastroenterol; 2023 Feb 21; 29(7):1131-1138. PubMed ID: 36926669
    [Abstract] [Full Text] [Related]

  • 19. Thalidomide for the treatment of bleeding angiodysplasias.
    Shurafa M, Kamboj G.
    Am J Gastroenterol; 2003 Jan 21; 98(1):221-2. PubMed ID: 12526972
    [No Abstract] [Full Text] [Related]

  • 20. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias.
    Garrido A, Sayago M, López J, León R, Bellido F, Márquez JL.
    Rev Esp Enferm Dig; 2012 Feb 21; 104(2):69-71. PubMed ID: 22372800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.